todays PPS may just reflect Isradapine delay, I can live with that. If the drugs delay is really worth six cents off of forty cents(if you consider that as the low evaluation) than so be it. We will just move on from here. I guess Lodrane is not coming back too. Now that was a real hit. This company with stay ahead of the curve even without Isradapine.
Market Data 
Markets 
AI
